Long-term safety and efficacy of opicapone in Japanese Parkinson’s patients with motor fluctuations
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-1463
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Long-term safety and efficacy of opicapone in Japanese Parkinson’s patients with motor fluctuations ; volume:128 ; number:3 ; day:25 ; month:2 ; year:2021 ; pages:337-344 ; date:3.2021
Journal of neural transmission ; 128, Heft 3 (25.2.2021), 337-344, 3.2021
- Creator
-
Takeda, Atsushi
Takahashi, Ryosuke
Tsuboi, Yoshio
Nomoto, Masahiro
Maeda, Tetsuya
Nishimura, Akihisa
Yoshida, Kazuo
Hattori, Nobutaka
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00702-021-02315-1
- URN
-
urn:nbn:de:101:1-2021050419433392389176
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Takeda, Atsushi
- Takahashi, Ryosuke
- Tsuboi, Yoshio
- Nomoto, Masahiro
- Maeda, Tetsuya
- Nishimura, Akihisa
- Yoshida, Kazuo
- Hattori, Nobutaka
- SpringerLink (Online service)
Other Objects (12)
Long-term safety and efficacy of adjunctive rasagiline in levodopa-treated Japanese patients with Parkinson’s disease
Safety and efficacy of tolcapone in Parkinson’s disease: systematic review
Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
Efficacy and safety of safinamide in Parkinson’s disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study
Gender differences in non-motor fluctuations in Parkinson’s disease
Home monitoring of motor fluctuations in Parkinson’s disease patients
Long-term safety and efficacy of frameless subthalamic deep brain stimulation in Parkinson’s disease
Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networks
Efficacy evaluation of multiple Parkinson’s disease vaccine candidates
Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Deciphering the effects of STN DBS on neuropsychiatric fluctuations in Parkinson’s disease
Long-term safety and efficacy of adjunctive rasagiline in levodopa-treated Japanese patients with Parkinson’s disease
Safety and efficacy of tolcapone in Parkinson’s disease: systematic review
Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
Efficacy and safety of safinamide in Parkinson’s disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study
Gender differences in non-motor fluctuations in Parkinson’s disease
Home monitoring of motor fluctuations in Parkinson’s disease patients
Long-term safety and efficacy of frameless subthalamic deep brain stimulation in Parkinson’s disease
Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networks
Efficacy evaluation of multiple Parkinson’s disease vaccine candidates
Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Deciphering the effects of STN DBS on neuropsychiatric fluctuations in Parkinson’s disease
Long-term safety and efficacy of adjunctive rasagiline in levodopa-treated Japanese patients with Parkinson’s disease
Safety and efficacy of tolcapone in Parkinson’s disease: systematic review
Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
Efficacy and safety of safinamide in Parkinson’s disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study
Gender differences in non-motor fluctuations in Parkinson’s disease
Home monitoring of motor fluctuations in Parkinson’s disease patients
Long-term safety and efficacy of frameless subthalamic deep brain stimulation in Parkinson’s disease
Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networks
Efficacy evaluation of multiple Parkinson’s disease vaccine candidates
Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study